Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
We'll I suppose its more work & some more cash coming in, but the company needs to be getting much bigger contracts of its own (not sub contractor work) to sustain & grow the business. £0K here & there won't do it.
Really need several £500K plus contracts so they can break-even at least with potential future royalties on top.
LOTM
Another £100k grant funded project there involved in, awarded in April this year:
https://gtr.ukri.org/projects?ref=10106193
The project's primary objective is to establish a local supply chain to produce Titan test kits. Causeway will use subcontractors to carry out critical elements of the kit assembly process. Fusion Antibodies, world experts in antibody production, will manufacture and purify an IgG1 monoclonal antibody, which will be used as the standard in the Titan test kits.
The project aims to generate real-time data by monitoring antibody production and purification processes at Fusion Antibodies. This data will be used to create application notes and technical documentation for Titan, providing valuable insights into its performance and applications.
Causeway Sensors anticipates that Titan will significantly impact biopharmaceutical manufacturing, introducing advanced process analytical testing (PAT) sensors for more efficient and data-informed manufacturing of biotherapeutics. The project reflects our commitment to local collaboration and expertise development in this field, contributing to increased activity in Northern Ireland's growing Life Sciences sector.
Decent day, more of the same tomorrow!
Decenday more of the same tomorrow
Well if you sold then you sold at the lowest point…..
You sold more the day before the 11am announcement of new deals/contracts? 🤔
Who’s your advisor? Donald . . . . Duck, not Trump? 🦆 💨
Took more risk off the table here
All these people saying they're buying yet the SP shows you what people are actually doing
Bulls moving it up.
Me too!
I also took a few extra!
Just a smidge but hopefully these prices will be history after presentation tomorrow
Yh
?
Are you BigJock from back in the imfamous Omega Diagnostic's day...Colin Kings mate ?
Just a waiting game, here. It will move up.
With so few shares in issue and so many in much higher the selling that held us back will dry up and we will move. Ipersonal see this price as a bit of a gift.
The next rns should give this a big bounce
I look forward to the presentation on Thursday
Stumbled across this:
https://gtr.ukri.org/projects?ref=studentship-2736498
Loooks like they’re part of a project which UKRI are funding Oxford uni for until 2026. Started in 2022 don’t remember it being announced.
Led by Professor Charlotte Deane - she’s on the FAB science panel and chair of Uk Engineering and Physical Science research council.
If I think back, Adrian said something about these guys making algorithms for Fusion in one of his presentations
This project will focus on machine learning techniques to select antibodies with the best biophysical properties. The project will be performed alongside experts in the field of applying machine learning to antibody development at the Oxford Protein Informatics Group of Professor Charlotte Deane and in collaboration with Fusion Antibodies. Fusion Antibodies have been experts in the antibody space for more than 20 years. Besides from harnessing this expertise, Fusion Antibodies will provide a wealth of valuable data linking antibody sequences to expression and various biophysical properties. This data will be used to design and create machine learning protocols and will be beneficial for this project as these types of datasets are rarely available to the public. Furthermore, experimental validation of algorithms could be performed by the company.
5-6p
Back above 4 this week
Technicals loooking more positive
263k buy gone through
And that’s just one contract!
CEO smiling and positive through interview So who are they….
1. ”A significant player that many of us will have heard of.”
2. .”A real global organisation.”
3. “Come to us for an antibody partner”
4. “Master service agreement”
5. “Continuing to do that” and “several other projects that we are running with those people, as we speak, so that’s great”
The money making day is coming soon.